Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Discover the crucial steps pharmaceutical manufacturers must take to assess and mitigate nitrosamine risks in drug products. Learn how meticulous risk assessment, rigorous testing, and proactive strategies ensure product safety and global compliance. Read on to protect your patients and
Dive deep into how nitrosamines, probable human carcinogens, can form during pharmaceutical manufacturing and the rigorous guidelines set by FDA and EMA to combat this risk. Discover the critical steps for risk assessment, testing, and mitigation that are ensuring drug